J Clin Endocrinol Metab (2021) 106:301933
View Canadian testing status & COAs Suggested Research Applications BPC-157 is frequently explored in laboratory environments for its potential roles in: Studies involving cellular protection and structural integrity Research on tissue behavior under stress or injury models Investigations into growth-factor interaction pathways Models examining vascular development and angiogenesis Experiments involving gastrointestinal peptide signaling Explorations of inflammatory response mechanisms Often researched with TB-500 and GHK-Cu (For laboratory research use only
Systematic dose titration across 610 sessions is necessary to identify the therapeutic dose for each subject
The peptide's anti-inflammatory actions extend systemically, with evidence showing injected GHK-Cu protects against cortisone-induced inhibition of wound healing in mice, rats, and pigs
It is not FDA-approved for weight loss: its clinical development was halted after Phase 2b, so any use is off-label and should be supervised by a licensed provider
You can lose fat and gain muscle simultaneously, especially early in a resistance training program, which may show minimal scale change despite significant physical transformation